Jove
Visualize
Contact Us

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

26
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
26
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

4.5K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
4.5K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

1.0K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

8.8K
The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
8.8K
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. Research Domains
  3. Biomedical And Clinical Sciences
  4. Oncology And Carcinogenesis
  5. Predictive And Prognostic Markers
  6. Association Of Vitamin D Levels With Multiple Sclerosis Activity And Progression In Patients Receiving Interferon Beta-1b.
  1. Home
  2. Research Domains
  3. Biomedical And Clinical Sciences
  4. Oncology And Carcinogenesis
  5. Predictive And Prognostic Markers
  6. Association Of Vitamin D Levels With Multiple Sclerosis Activity And Progression In Patients Receiving Interferon Beta-1b.

Related Experiment Video

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.

Kathryn C Fitzgerald1, Kassandra L Munger1, Karl Köchert2

  • 1Department of Nutrition, Harvard T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts.

JAMA Neurology
|October 13, 2015

View abstract on PubMed

Summary
This summary is machine-generated.

Higher serum 25-hydroxyvitamin D (25[OH]D) levels correlate with reduced new MRI lesions in multiple sclerosis (MS) patients treated with interferon beta-1b. However, associations with brain atrophy and clinical progression were less clear.

More Related Videos

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.9K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.1K

Related Experiment Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.9K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.1K

Area of Science:

  • Neurology
  • Immunology
  • Endocrinology

Background:

  • Low serum 25-hydroxyvitamin D (25[OH]D) is linked to increased multiple sclerosis (MS) risk and activity.
  • Understanding the role of 25[OH]D in MS disease course is crucial for patient management.

Purpose of the Study:

  • To investigate the association between serum 25[OH]D levels and disease progression in relapsing-remitting MS patients receiving interferon beta-1b.
  • To evaluate the impact of 25[OH]D on MRI-defined disease activity and clinical outcomes.

Main Methods:

  • Prospective cohort study of 1482 MS patients from the BEYOND clinical trial.
  • Serum 25[OH]D levels measured at baseline, 6, and 12 months.
  • Disease activity assessed via MRI (lesions, brain volume) and clinical measures (relapse rate, EDSS) over at least 2 years.

Main Results:

  • Higher serum 25[OH]D levels were significantly inversely correlated with the cumulative number of new active MRI lesions.
  • A 50.0-nmol/L increase in 25[OH]D was associated with a 31% reduction in new lesions.
  • No significant associations were found between 25[OH]D levels and brain volume changes, relapse rates, or EDSS scores.

Conclusions:

  • In MS patients treated with interferon beta-1b, elevated 25[OH]D levels are associated with reduced MRI-detected disease activity.
  • The impact of 25[OH]D on brain atrophy and clinical progression in MS remains less definitive.